Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial.
Dzienis M, Cundom J, Fuentes CS, Spreafico A, Nordlinger M, Pastor AV, Alesi E, Neki A, Fung AS, Figueiredo Lima IP, Oppelt P, da Cunha Junior GF, Burtness B, Franke FA, Tseng JE, Joshi A, McCarthy J, Swaby R, Sidi Y, Gumuscu B, Naicker N, de Castro G Jr. Dzienis M, et al. Among authors: oppelt p. J Clin Oncol. 2024 Sep 1;42(25):2989-2999. doi: 10.1200/JCO.23.02625. Epub 2024 Jul 22. J Clin Oncol. 2024. PMID: 39038265 Free PMC article. Clinical Trial.
Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial.
Vergote I, Scambia G, O'Malley DM, Van Calster B, Park SY, Del Campo JM, Meier W, Bamias A, Colombo N, Wenham RM, Covens A, Marth C, Raza Mirza M, Kroep JR, Ma H, Pickett CA, Monk BJ; TRINOVA-3/ENGOT-ov2/GOG-3001 investigators. Vergote I, et al. Lancet Oncol. 2019 Jun;20(6):862-876. doi: 10.1016/S1470-2045(19)30178-0. Epub 2019 May 7. Lancet Oncol. 2019. PMID: 31076365 Free article. Clinical Trial.
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.
du Bois A, Kristensen G, Ray-Coquard I, Reuss A, Pignata S, Colombo N, Denison U, Vergote I, Del Campo JM, Ottevanger P, Heubner M, Minarik T, Sevin E, de Gregorio N, Bidziński M, Pfisterer J, Malander S, Hilpert F, Mirza MR, Scambia G, Meier W, Nicoletto MO, Bjørge L, Lortholary A, Sailer MO, Merger M, Harter P; AGO Study Group led Gynecologic Cancer Intergroup/European Network of Gynaecologic Oncology Trials Groups Intergroup Consortium. du Bois A, et al. Lancet Oncol. 2016 Jan;17(1):78-89. doi: 10.1016/S1470-2045(15)00366-6. Epub 2015 Nov 16. Lancet Oncol. 2016. PMID: 26590673 Free article. Clinical Trial.
Socioeconomic status as a risk factor for SARS-CoV-2 infection in pregnant women.
Lastinger J, Gerich J, Beham-Rabanser M, Stelzl P, Trautner PS, Enzelsberger SH, Altmann R, Shebl O, Oppelt P, Enengl S. Lastinger J, et al. Among authors: oppelt p. J Perinat Med. 2024 Aug 23;52(8):817-823. doi: 10.1515/jpm-2024-0235. Print 2024 Oct 28. J Perinat Med. 2024. PMID: 39190862 Free article.
S2k-Guideline Non-hormonal Contraception, Part 2: Intrauterine Devices and Sterilization: Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015 - 095, January 2024).
Böttcher B, Beckermann MJ, Berger B, Cremers JF, DʼCosta E, Frank-Herrmann P, Freundl-Schütt T, Friedrich C, Funck S, Gathmann C, Goeckenjan M, Goette S, Hancke K, Leiber-Caspers C, Maeffert J, Merki G, Oppelt P, Renteria SC, Richter-Unruh A, Schäfer SD, Schardt AR, Schernus N, Schumann-Doermer C, Seyler H, Sieber C, Sonntag B, Stöcker G, Toth B, Tunkel A, Wallwiener LM, Segerer S. Böttcher B, et al. Among authors: oppelt p. Geburtshilfe Frauenheilkd. 2024 Aug 6;84(8):715-736. doi: 10.1055/a-2317-8993. eCollection 2024 Aug. Geburtshilfe Frauenheilkd. 2024. PMID: 39114382 Free PMC article.
S2k-Guideline Non-hormonal Contraception, Part 1: Natural Family Planning, Lactational Amenorrhea, Barrier Methods, Coitus Interruptus: Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015 - 095, January 2024).
Böttcher B, Beckermann MJ, Berger B, Cremers JF, DʼCosta E, Frank-Herrmann P, Freundl-Schütt T, Friedrich C, Funck S, Gathmann C, Goeckenjan M, Goette S, Hancke K, Leiber-Caspers C, Maeffert J, Merki G, Oppelt P, Renteria SC, Richter-Unruh A, Schäfer SD, Schardt AR, Schernus N, Schumann-Doermer C, Seyler H, Sieber C, Sonntag B, Stöcker G, Toth B, Tunkel A, Wallwiener LM, Segerer S. Böttcher B, et al. Among authors: oppelt p. Geburtshilfe Frauenheilkd. 2024 Aug 6;84(8):697-714. doi: 10.1055/a-2317-9133. eCollection 2024 Aug. Geburtshilfe Frauenheilkd. 2024. PMID: 39114381 Free PMC article.
234 results